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Two Distinct Pathways in Mice 
generate antinuclear antigen-
reactive B cell repertoires
Martin Faderl†‡, Fabian Klein‡, Oliver F. Wirz†‡, Stefan Heiler, Llucia Albertí-Servera,  
Corinne Engdahl, Jan Andersson* and Antonius Rolink
Developmental and Molecular Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland
The escape of anti-self B cells from tolerance mechanisms like clonal deletion, receptor 
editing, and anergy results in the production of autoantibodies, which is a hallmark 
of many autoimmune disorders. In this study, we demonstrate that both germline 
sequences and somatic mutations contribute to autospecificity of B cell clones. For this 
issue, we investigated the development of antinuclear autoantibodies (ANAs) and their 
repertoire in two different mouse models. First, in aging mice that were shown to gain 
several autoimmune features over time including ANAs. Second, in mice undergoing a 
chronic graft-versus-host disease (GVHD), thereby developing systemic lupus erythema-
tosus-like symptoms. Detailed repertoire analysis revealed that somatic hypermutations 
(SHM) were present in all Vh and practically all Vl regions of ANAs generated in these 
two models. The ANA B  cell repertoire in aging mice was restricted, dominated by 
clonally related Vh1-26/Vk4-74 antibodies. In the collection of GVHD-derived ANAs, the 
repertoire was less restricted, but the usage of the Vh1-26/Vk4-74 combination was 
still apparent. Germline conversion showed that the SHM in the 4-74 light chain are 
deterministic for autoreactivity. Detailed analysis revealed that antinuclear reactivity of 
these antibodies could be induced by a single amino acid substitution in the CDR1 of the 
Vk4-74. In both aging B6 and young GVHD mice, conversion of the somatic mutations in 
the Vh and Vl regions of non Vh1-26/Vk4-74 using antibodies showed that B cells with 
a germline-encoded V gene could also contribute to the ANA-reactive B cell repertoire. 
These findings indicate that two distinct pathways generate ANA-producing B cells in 
both model systems. In one pathway, they are generated by Vh1-26/Vk4-74 expressing 
B cells in the course of immune responses to an antigen that is neither a nuclear antigen 
nor any other self-antigen. In the other pathway, ANA-producing B cells are derived from 
progenitors in the bone marrow that express B cell receptors (BCRs), which bind to 
nuclear antigens and that escape tolerance induction, possibly as a result of crosslinking 
of their BCRs by multivalent determinants of nuclear antigens.
Keywords: antinuclear antibodies, autoantibodies, monoclonal antibodies, mouse model, systemic lupus 
erythematosus-like disease, somatic hypermutation
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inTrODUcTiOn
A hallmark of the autoimmune disease systemic lupus erythema-
tosus (SLE) is the presence of antinuclear autoantibodies (ANAs) 
in the serum (1–6). These antibodies are directed against histones, 
DNA, histone–DNA complexes, and various ribonuclear com-
plexes (anti-SM, anti-Ro, and anti-La) (3–6) and may be found in 
immune complexes that play an important role in the pathogen-
esis of SLE. The disease occurs more frequently in females than 
males (ratio 10:1) with a peak incidence at 45–65 years. Based 
on the findings that ANA producing B cells have undergone Ig 
class switching and carry large numbers of somatic mutations, it 
is very likely that ANAs arise from B cells participating in T cell 
dependent antigen responses (3–6).
Studies using mouse models spontaneously developing an 
SLE-like disease have improved our knowledge of the etiology of 
this disease (7–9). In particular, these studies have highlighted the 
complex genetic contribution to the development of the disease as 
well as the important role of somatic mutations of antibody genes 
in the formation of autoantibodies (7–13).
The generation of a self-tolerant B cell repertoire is critically 
dependent upon the processes of clonal deletion, receptor editing, 
and anergy (14–19). Exactly how B cells escape central tolerance 
is, however, still not completely understood. Ample evidence 
has been provided indicating that non-autoreactive B cells can 
become autoreactive through somatic mutations in their variable 
heavy (Vh) and light (Vl) chain regions (6, 10, 13, 20). Equally, 
B cells using germline-encoded Vh and Vl regions escaping cen-
tral tolerance induction in the bone marrow could also generate 
autoreactive B cells (21).
Recently we showed that almost all aging (8–12 months old) 
C57BL/6 (B6) mice develop several features characteristic of 
autoimmunity. This included germinal center formations in the 
spleen, kidney depositions of IgM, lymphocyte infiltrates in the 
salivary glands, as well as the production of high titers of IgG 
ANAs. Furthermore, this IgG ANA generation was shown to be 
T cell dependent (22). However, aging B6 mice do not develop 
real signs of disease. Here, we compare the ANA B cell repertoire 
of such aging B6 mice with that of (B6 ×  B6.H-2bm12)F1 mice 
undergoing a chronic graft-versus-host disease (cGVHD) and 
thus developing an SLE-like disease and death (23). Results 
indicate that the ANA B cell repertoire of aging B6 mice is more 
restricted than that of mice undergoing GVHD and is only 
partially overlapping. Moreover, we show that the ANA produc-
ing B cells in aging mice and in GVHD mice are derived from 
progenitors expressing B cell receptors (BCRs) either recognizing 
or not recognizing nuclear antigens. These findings indicate that 
ANA producing B cells in both aging mice and in GVHD mice are 
generated by two pathways: by defective tolerance induction in 
the bone marrow or by hypermutation in the V-regions of B cells 
responding to a foreign antigen.
MaTerials anD MeThODs
Mice and induction of cgVhD
C57BL/6 and (C57BL/6 × B6(C)-H2-Abbm12/KhEgJ)F1 mice were 
bred under specific pathogen free conditions in our animal unit. 
A cGVHD was induced by i.v. injection of 8 × 107 spleen plus 
lymph node cells from B6 mice into 8–10 weeks old B6 × bm12 
mice, following established protocols (23).
generation of hybridomas
Spleen cells derived from aging B6 mice (aged 8–12  months) 
or B6 ×  bm12 mice undergoing a cGVHD were fused to the 
Sp2/0-Ag14 fusion partner following standard protocols. In 
brief, 2 ×  107 Sp2/0 cells were used for the PEG1500 (Roche 
Diagnostics)-mediated fusion of all lymphoid cells prepared 
from an entire spleen. The fused cells were plated into 25 flat-
bottom 96-well plates containing 200 µl HAT-medium (2%FBS; 
GIBCO, 2% IL6, in house, 1× HAT supplement, Sigma) per 
well and incubated at 37°C in 10% CO2 in air. After 10–12 days, 
supernatants were tested for IgG production by ELISA and for 
antinuclear reactivity by immunofluorescence (see below). Cells 
from IgG ANA positive wells were thereafter sub-cloned at limit-
ing dilution. We routinely obtained fusion frequencies between 
10−3 and 5  ×  10−3. Thus, for each mouse, we have screened 
between 5,000 and 20,000 hybrids for IgG ANA production. 
Since the vast majority of B cell hybrids produce IgM, we tested 
for the success of sub-cloning by performing simultaneous 
ELISA for IgM and IgG (see below) in supernatants of growing 
clones. The IgG containing supernatants were re-tested for ANA 
reactivity, before being further processed for Ig V-gene analyses 
(see below).
Determination of igg sub-class and anti-
histone/Dna/sm/ss-B/la reactivity
Determination of IgG sub-class, l-chain, and detection of anti-
DNA antibodies was done by standard ELISA. For determination 
of anti-histone, anti-Sm or anti-SS-B/La ELISA plates were coated 
with 2.5 μg/ml of the respective antigens in PBS (all purchased 
from Immunovision). Alkaline phosphatase labeled goat anti-
mouse IgG, goat anti-mouse l-chain or goat anti-human IgG 
(Southern Biotech) was used for detection. The ELISA was 
performed as previously described (24–26).
antinuclear autoantibody Determination
Kidney cryosections from Rag2−/− mice of homozygous mat-
ings were incubated with supernatants or purified antibodies 
as described in Ref. (27). For detection, either FITC labeled 
goat anti-mouse IgG (Jackson ImmunoResearch) or FITC 
labeled rabbit anti-human IgG (Jackson ImmunoResearch) 
were used.
Vh and Vl sequencing analysis
RNA from ANA positive hybridomas was extracted using TRI 
Reagent (Sigma) followed by cDNA synthesis (GoScript Reverse 
Transcriptase) according to the manufacturer’s protocol and 
using primers as specified in Table S5 in Supplementary Material. 
Amplification of the heavy and light chain V-regions was per-
formed using Vent polymerase (New England Biolabs) and, 
subsequently, the Vh and Vl regions were ligated into the pJet1.2 
blunt end cloning vector (Thermo Fisher Scientific). For sequenc-
ing, plasmids were sent to Microsynth (Balgach, Switzerland). 
TaBle 1 | Characteristics of ANA-reactive mAbs derived from aging B6 mice.a,b
Mouse number hybridoma number igg isotype ig-heavy chain v-region ig-light chain v-region
Aging B6 # 1 5.D3.D10 IgG2b Vh1-26 D1-1 J4 Vk4-74 Jk4
5.D3. E12 IgG2b Vh1-26 D1-1 J4 Vk4-74 Jk4
7.E8.B11 IgG2b Vh1-26 D1-1 J4 Vk4-74 Jk4
7.F9.F1 IgG2b Vh1-75 D2-4 J2 Vk?
8G3.E6 IgG2a Vh1-26 D1-1 J4 Vk4-74 Jk4
8.H7.D3 IgG2b Vh1-26 D1-1 J4 Vk4-74 Jk4
15.G10.F10 IgG2b Vh1-26 D1-1 J4 Vk4-74 Jk4
15.H12.E4 IgG2b Vh1-26 D1-1 J4 Vk4-74 Jk4
16.B9.C9 IgG2b Vh1-26 D1-1 J4 Vk4-74 Jk4
16.D7.A9 IgG2a Vh1-26 D1-1 J4 Vk4-74 Jk4
17.A9.E6 IgG2b Vh1-26 D1-1 J4 Vk4-74 Jk4
22.C9.G7 IgG2b Vh1-26 D1-1 J4 Vk4-74 Jk4
Aging B6 # 2 1.G5.B8 IgG1 Vh1-39 D4-1 J1 Vk4-57 Jk5
8.G9.G4 IgG2b Vh1-26 D1-1 J4 Vk6-32 Jk2
Aging B6 # 3 13.4.5.A IgG2a Vh1-26 D2-4 J3 Vk4-74 Jk2
13.18.A IgG2a Vh1-26 D2-4 J3 Vk4-74 Jk2
13.27.B IgG2a Vh1-26 D2-4 J3 Vk4-74 Jk2
13.31A IgG2a Vh1-26 D2-4 J3 Vk4-74 Jk2
13.69.B IgG2a Vh1-26 D2-4 J3 Vk4-74 Jk2
13.85B IgG2a Vh1-26 D2-4 J3 Vk4-74 Jk2
Aging B6 # 4 1A2.1 IgG2a Vh1-26 D2-2 J4 Vk4-74 Jk2
2F8.1 IgG2b Vh1-26 D1-1 J4 Vk4-74 Jk2
Aging B6 # 5 12.G3.G7 IgG2a Vh1-26 D1-1 J4 Vk5-43 Jk2
15.D10B3 IgG2a Vh1-26 D1-1 J4 Vk5-43 Jk2
Aging B6 # 6 3.2.2A IgG2b Vh1-74 D2-4 J3 Vk6-23 Jk5
3.10.1A IgG2b Vh1-26 D1-1 J2 Vk4-61 Jk1
5.13.1A IgG2b Vh1-26 D1-1 J2 Vk4-74 Jk2
6.15.1A IgG2a Vh8-12 D3-1 J1 Vk4-91 Jk2
7.7.3A IgG2b Vh1-22 D2-2 J1 Vk10-96 Jk2
20.15.1A IgG2a Vh1-50 D4-1 J2 Vk4-74 Jk2
23.6.1A IgG2a Vh1-22 D2-2 J1 Vk10-96 Jk2
24.18.1A IgG2b Vh1-22 D2-2 J1 Vk10-96 Jk2
25.8.1A IgG2b Vh3-6 D3-3 J3 Vk4-74 Jk2 
Aging B6 # 7 3.25A IgG2b Vh1-50 D2-4 J2 Vk?
3.36A IgG2a Vh1-80 D2-4 J3 Vk4-58 Jk2
3.73A IgG2a Vh1-26 D1-1 J4 Vk4-74 Jk2
aAll the mAbs converted into germline sequences are boxed in orange.
bAll the mAbs using Vh1-26 have been boxed in yellow and those using Vk4-74 in red.
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Resulting sequences were inspected using DNASTAR and 
aligned to the germline heavy and light chain sequences of the 
international ImMunoGeneTics information system® (http://
imgt.org).
reversion of somatic Mutations Back into 
germline configuration
Double-stranded DNA encoding the variable regions of heavy and 
light chains obtained from ANA positive hybridomas as well as 
their germline and mutated versions were ordered as gBlock gene 
fragments from IDT (Integrated DNA Technologies). These frag-
ments were cloned into heavy and light chain expression vectors 
driven by the human cytomegalovirus promoter and containing 
the human IgG1 constant region for the heavy chain and the human 
kappa constant region for the light chain (28) (a kind gift from 
Dr. Hedda Wardemann, Deutsches Krebsforschungszentrum, 
Heidelberg, Germany). Subsequently, antibodies were produced 
in HEK 293 cells (ATCC, No. CRL-1573) and purified by affinity 
chromatography on Protein A Sepharose® (GE Health Care, 
Uppsala, Sweden) as described (28, 29).
resUlTs
igg ana Producing hybridomas from 
aging B6 Mice
Hybridomas were generated independently from spleen cells of 
seven individual aging B6 mice, which had high titers of serum 
ANA. The resulting IgG producing hybridomas were then tested 
for ANA reactivity by immunofluorescence, and positive cultures 
were sub-cloned. In total, 36 hybridomas producing IgG ANA 
were generated (Table 1). Of these, 16 were IgG2a, 19 were IgG2b, 
and only one was IgG1. This heavy chain selection suggests 
that IgG ANA formation in aging B6 mice is mainly driven by 
a Th1 response (30). All ANAs contained a kappa light chain. 
Sequence analysis of the corresponding Vh and Vk regions used 
by these hybridomas revealed a restricted repertoire (V, D, and 
FigUre 1 | ANA reactivity is directed against histones. Histone, dsDNA, ssDNA, Sm, or SS-B/La binding of ANA-reactive mAbs derived from (a) aging B6 (Table 1) 
or (B) young B6 × bm12 mice undergoing a cGVH reaction (Table 2). Significant binding was defined as an O.D. of five times over background in ELISA. (−), no 
significant binding at 5 μg/ml; (+), binding at 5 μg/ml; (++), binding at 1.7 µg/ml; (+++), binding at 0.55 µg/ml; and (++++), binding at 0.19 µg/ml or lower.
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J annotations are according to the IMGT data base). Thus, 25 
(69.4%) hybridomas used the Vh1-26 gene and this usage was 
found among hybridomas of all seven individual mice. Moreover, 
a very high frequency of Vk4-74 gene usage was also found. Thus, 
23 (63.9%) hybridomas, derived from 5 of 7 individual mice, used 
this particular Vk light chain gene. Strikingly, 21 of the 23 Vk4-74 
expressing hybridomas expressed the Vh1-26 heavy chain. Thus, 
the IgG ANA B cell repertoire of aging B6 mice is dominated by 
those expressing a Vh1-26 heavy chain gene in combination with 
a Vk4-74 light chain gene.
We also tested these ANAs for their capacity to bind to 
histones, Sm antigens, SS-B/La antigens, and DNA. By ELISA, 
26 of the 36 showed strong and 5 showed weak histone binding, 
whereas binding to the other nuclear antigens was undetectable 
(Figure 1A).
in individual Mice, hybridomas Using 
Vh1-26/Vk4-74 Were clonally related
The fact that we obtained 11 hybridomas from mouse 1, and 6 
hybridomas from mouse 3 using the Vh1-26/Vk4-74 combination 
with the same D, Jh, and Jk elements already strongly suggested 
a clonal relationship among the B cells that had fused to gener-
ate these hybridomas (Table 1). The finding that the amino acid 
sequences of the IgH and IgL CDR3 regions of these hybridomas 
were practically identical (Tables S1 and S2 in Supplementary 
Material) also supports this conclusion. Thus, at least in mouse 
1 and 3, the ANA production seems to be dominated by a single 
B cell clone.
igg ana from B6 × bm12 Mice 
Undergoing a chronic graft-versus-host 
reaction
We then asked whether the restricted IgG ANA B cell repertoire 
in aging B6 mice, which do not show obvious signs of disease, was 
similarly restricted in B6 × bm12 mice undergoing a chronic graft-
versus-host reaction and, thus, developing an SLE-like disease. 
Hybridomas were independently generated from spleen cells of 
five mice with the highest ANA titers. These fusions resulted in 34 
hybridomas with IgG ANA activity (Table 2). A total of 23 ANAs 
(68%) reacted to histones but again, none reacted to the other 
nuclear antigens (Figure 1B). IgG constant region usage analysis 
revealed a distribution rather similar to that in aged mice with 18 
IgG2a, 13 IgG2b, and only 3 IgG1, the latter all from mouse 5. Thus, 
as in aging B6 mice, in B6 × bm12 mice undergoing a cGVHD, 
the IgG ANA formation appears to be Th1 cell driven. Again, all 
ANAs contained a kappa light chain.
TaBle 2 | Characteristics of ANA-reactive mAbs derived from graft-versus-host 
disease (GVHD) mice.a,b
Mouse 
number
hybridoma 
number
igg 
isotype
ig-heavy chain 
v-region
ig-light chain 
v-region
GVHD # 1 1.12.1A IgG2b Vh8-8 D2-14 J4 Vk4-74 Jk2
1.28.1 IgG2a Vh1-26 D1-1 J1 Vk4-74 Jk2
1.308.1 IgG2a Vh1-55 D2-4 J3 Vk3-4 Jk1
1.356.1 IgG2a Vh1-55 D2-4 J3 Vk3-4 Jk1
1.741.1 IgG2a Vh1-55 D2-4 J3 Vk3-4 Jk1
1.802.1 IgG2b Vh1-26 D1-1 J1 Vk4-63 Jk5
GVHD # 2 2.24.0 IgG2a Vh1-52 D1-1 J1 Vk14-111 Jk5
2.53.8 IgG2b Vh14-2 D2-2 J2 Vk14-111 Jk1
2.58.2 IgG2b Vh14-2 D2-2 J2 Vk14-111 Jk1
2.70.8 IgG2a Vh14-4 D1-1 J3 Vk3-10 Jk1
2.80.9 IgG2a Vh14-4 D1-1 J3 Vk3-12 Jk1
2.152.9 IgG2a Vh1-52 D1-1 J1 Vk3-10 Jk1
2.300.2 IgG2b Vh1-55 D2-1 J2 Vk3-10 Jk5
2.344.3 IgG2a Vh1-52 D1-1 J1 Vk14-111 Jk5
2.374.1 IgG2a Vh1-26 D1-1 J1 Vk3-7 Jk1
2.382.2 IgG2a Vh14-4 D2-1 J3 Vk3-10 Jk1
2.388.2 IgG2a Vh1-31 D2-4 J4 Vk3-10 Jk2
2.394.1 IgG2a Vh14-4 D1-1 J3 Vk3-10 Jk1
GVHD # 3 3.55.1 IgG2a Vh1-26 D1-1 J3 Vk4-74 Jk2
3.69.1 IgG2b Vh1-26 D1-1 J3 Vk4-74 Jk2
3.71.1 IgG2a Vh1-26 D2-5 J1 Vk4-74 Jk2
3.77.1 IgG2a Vh1-26 D1-1 J3 Vk4-74 Jk2
3.152.1 IgG2b Vh1-26 D1-1 J3 Vk4-74 Jk2
GVHD # 4 63.3.1 IgG2b Vh1-55 D2-4 J2 Vk4-74 Jk2
165.2.1 IgG2a Vh8-12 D2-2 J1 Vk15-103 Jk5
GVHD # 5 14.11.A IgG2b Vh1-50 D1-1 J2 Vk1-117 Jk2
381.11.A IgG2b Vh1-54 J4 Vk14-111 Jk2
685.9.A IgG2b Vh1-59 D2-5 J3 Vk17-127 Jk5
724.3.A IgG1 Vh1-26 D1-1 J3 Vk4-91 Jk4
738.8.A IgG1 Vh1-26 D1-1 J3 Vk3-7 Jk1
762.5.A IgG2a Vh5-17 D1-2 J4 Vk?
810.4.A IgG1 Vh1-52 D2-12 J2 Vk3-10 Jk1
865.12.A IgG2b Vh1-72 D3-3 J2 Vk4-74 Jk5
1011.39.A IgG2b Vh1-53 D1-1 J2 Vk17-127 Jk5
aAll the mAbs converted into germline sequences are boxed in orange.
bAll the mAbs using Vh1-26 are boxed in yellow and those using Vk4-74 in red.
5
Faderl et al. Two Pathways Generate Autoreactive Antibodies
Frontiers in Immunology | www.frontiersin.org January 2018 | Volume 9 | Article 16
results are summarized in Tables S1–S4 in Supplementary 
Material.
Since in aging B6 mice the ANA reactivity was dominated 
by mAbs expressing a Vh1-26/Vk4-74 heavy and light chain 
combination, we tested if somatic mutations in the Vh and/or 
the Vk regions of these mAbs were required for their autore-
activity. Therefore, the Vh and Vk regions of six (derived from 
4 individual mice) mAbs of aging B6 and two mAbs of GVHD 
mice using the Vh1-26/Vk4-74 combination were reverted to 
their germline configuration. After expression and purification, 
the ANA titers of these reverted mAbs were directly compared 
to their original, mutated forms. As shown in Figures  2A,B, 
the ANA titers of all mAbs, in which the Vh region had been 
reverted into germline configuration but the Vk regions were still 
somatically mutated, behaved like the original ANAs, continuing 
to recognize the histone antigens. However, all mAbs where the 
Vh was still somatically mutated but the Vk had been reverted to 
germline configuration lost ANA reactivity. Also, as expected, all 
mAbs in which both Vh and Vkappa regions had been reverted 
to germline configuration lost ANA reactivity. Thus, the ANA 
reactivity of the Vh1-26/Vk4-74 mAbs is due to somatic muta-
tions in the Vk4-74 gene.
Due to the finding that somatic mutations within the Vk4-74 
gene determined the ANA reactivity of Vh1-26/Vk4-74 mAbs 
and in order to identify a common motif that could account for 
this autoreactivity, we analyzed the sequence of these Vk4-74 
genes in more detail. This analysis revealed that 20 of 23 Vh1-26/
Vk4-74 mAbs derived from aging B6 mice had a mutation at posi-
tion 30 (IMGT numbering) in their CDR1 region of the Vk4-74 
gene. The germline-encoded serine in these mAbs was mutated 
into a positively charged arginine residue. Introduction of such 
a serine to arginine mutation in non-autoreactive germline ver-
sions of three different mAbs resulted in a complete gain of ANA 
reactivity for all of them (Figure 2C). Thus, antinuclear reactivity 
of these mAbs can be induced by a single base pair substitution 
changing the serine at position 30 in the CDR1 of the Vk4-74 light 
chain into an arginine.
B cells expressing a germline-encoded 
immunoglobulin Vh gene with a 
negatively charged cDr2 region 
contribute to the ana-reactive B cell 
repertoire
We also tested if non-Vh1-26/Vk4-74 using mAbs require 
somatic mutations in their Vh and/or Vk regions for ANA reac-
tivity. Therefore, the Vh and Vk region of three mAbs of aging 
B6 mice and six mAbs of the GVHD mice were reverted to their 
germline configuration. The 1.G5.B8 mAb derived from an aging 
B6 mouse (No. 2) used a somatically mutated Vh region and a 
germline-encoded Vk region. Reversion of the Vh region of this 
mAb into germline sequences resulted in a complete abrogation 
of its ANA reactivity (Figure 3A). In contrast, upon reversion, 
the other two mAbs (7.7.3A and 6.15.1A, both from mouse 6) 
kept their ANA reactivity (Figure 3A). Thus, B cells expressing 
a germline-encoded immunoglobulin Vh can also contribute to 
the ANA-reactive B cell repertoire in aging B6 mice.
In aging B6 mice, a dominance of Vh1-26 and Vk4-74 
usage by the IgG ANA producing hybridomas was observed. In 
B6 × bm12-derived hybridomas, the same genes were also found 
to be used, but at a much lower frequency. Thus, ten (29.4%) of 
these ANAs used Vh1-26 and nine (26.5%) used Vk4-74. Six of the 
hybridomas using Vk4-74 used the Vh1-26 heavy chain; however, 
five of these were derived from one mouse (GVHD mouse 3). 
These findings show that the IgG ANA B cell repertoires of aging 
B6 mice and B6 × bm12 mice undergoing a cGVHD are partially 
overlapping. However, the IgG ANA B cell repertoire seems to be 
more diverse in the B6 × bm12 mice than in the aging B6 mice. 
Therefore, the mechanisms underlying the generation of these 
autoreactive B cells might be different in the two model systems.
somatic Mutations in the light chain 
Determine the ana reactivity of Vh1-26/
Vk4-74 Using mabs
Sequence analysis revealed that most mAbs with ANA reactivity 
carried somatic mutations in their Vh and Vk regions. These 
FigUre 2 | ANA reactivity of Vh1-26/Vk4-74 using mAbs is caused by mutations in the light chain. ANA titers of different Vh1-26/Vk4-74 mAbs derived from (a) 
aging B6 (Table 1) or (B) young B6 × bm12 mice undergoing a cGvH reaction (Table 2). The histograms depict titers of individual mAbs, either with the original 
SHM, or Vh and/or Vk in germline configuration (GL), or (c) having a single mutation in their Vk CDR1 resulting in a serine to arginine conversion. A titer of one was 
defined as binding at a concentration of 5 µg/ml mAb, followed by 1:2 serial dilution steps and recording the last dilution where binding still was possible. SHM, 
somatic hypermutation; GL, germline; n.b., no binding detectable at 5 µg/ml of mAb.
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From the six GVHD-derived mAbs, one (1.12.1A, mouse 1) 
lost ANA reactivity upon reversion of the Vk but not the Vh gene 
into germline configuration (Figure 3B). The fact that this mAb 
uses the Vk4-74 gene indicates that this Vk gene can also give rise 
to ANA reactivity when paired with a Vh gene other than Vh1-26. 
The other five mAbs kept their ANA reactivity upon reversion of 
their Vh and Vk genes to germline configuration (Figure 3B). 
Thus, B  cells expressing a germline-encoded immunoglobulin 
can also contribute to the ANA-reactive repertoire in mice 
undergoing a cGVHD.
A remarkable observation was that 5 of 7 mAbs (one from 
aging B6 mice and four from GVHD mice), which kept ANA 
reactivity upon complete reversion of their Ig genes into germline 
configuration, had a negatively charged Vh-CDR2 region as 
defined by having at least two more negatively than positively 
charged amino acids in this region (see Table 3). This observa-
tion prompted us to test if these negatively charged amino acids 
are involved in ANA reactivity. Therefore, the negatively charged 
amino acids in the CDR2 regions of these five mAbs were mutated 
into neutral glycine. As shown in Figure 3C, one mAb derived 
from an aging B6 mouse (6.15.1A) and two from a GVHD mouse 
(2.58.2 and 2.394.1), completely lost ANA reactivity upon aspar-
tic acid/glutamic acid conversion into glycine. The ANA titers 
of the other two GVHD-derived mAbs (2.344.3 and 165.2.1) 
diminished by a factor of 2 and 3, respectively (Figure 3C). Thus, 
B  cells expressing a germline-encoded immunoglobulin with 
a negatively charged Vh-CDR2 region contribute to the ANA-
reactive repertoire. At this point, it is noteworthy that 6 of 11 
(54.6%) of the non-Vh1-26 using ANA mAbs from aging B6 mice 
and 14 of 24 (58.3%) from mice undergoing cGVHD indeed carry 
a negatively charged Vh-CDR2 (Table 3).
DiscUssiOn
Two Pathways to ana-Producing B cells
In the present study, we compared antinuclear autoantibodies 
(ANAs) from aging B6 mice, which do not show signs of disease, 
with those derived from mice undergoing a chronic GVH reac-
tion (GVHD mice) and which develop an SLE-like disease (23). 
In order to study the V-regions of ANAs, we generated B  cell 
hybridomas from mice with high ANA titers in their serum. 
Almost all monoclonal ANAs bound to a mixture of histones. As 
expected from previous studies, ANA production was T cell and 
antigen dependent (1–3, 22), since virtually all V-regions of our 
monoclonal ANAs contained somatic mutations. To determine 
whether the ANA-producing B cells were derived from progeni-
tors expressing B cell receptors (BCRs) for nuclear antigens, we 
reverted the mutated V-regions into the corresponding germline 
sequences and tested the resulting antibodies for ANA reactivity. 
Based on such analyses, we found that some ANA-producing 
B cells in both aging B6 mice and GVHD mice must be derived 
FigUre 3 | ANA reactivity of non-Vh1-26/Vk4-74 using mAbs is mainly germline encoded. ANA titers of different non-Vh1-26/Vk4-74 mAbs derived from (a) aging 
B6 or (B) young B6 × bm12 mice undergoing a chronic graft-versus-host disease. The histograms depict titers of individual mAbs listed in Table 3 containing 
V-regions, either with the original somatic hypermutations (SHM), or Vh and/or Vk in germline configuration (GL), or (c) containing a Vh CDR2 with conversions of 
aspartic and glutamic acids to glycine. Titers and legends as defined in Figure 2.
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from progenitors expressing germline-encoded genes for BCRs 
specific for nuclear antigens, while several others were derived 
from progenitors expressing BCRs that showed no ANA reactiv-
ity. The vast majority of the latter were derived from progenitors 
using Vh1-26 in combination with Vk4-74. Antibodies with the 
germline sequences of these V-regions had no ANA reactivity. 
It has been shown previously that non-autoreactive B  cells 
can become autoreactive upon acquiring somatic mutations 
in their Vh and/or Vl regions (6, 10, 13, 20). In contrast to the 
findings with Vh1-26/Vk4-74 expressing ANAs, the reversion 
of other Vh and Vk regions of several monoclonal ANAs to 
the corresponding germline sequences did not abolish ANA 
reactivity. The maintenance of ANA reactivity upon reversion 
into germline sequences was observed with 2 of 3 monoclonal 
ANAs from aging B6 mice, and with 5 of 6 monoclonal ANAs 
from GVHD mice. Thus, two pathways can be envisaged for the 
generation of ANA specific antibody forming B cells (Figure 4). 
In pathway one, they are derived from B cells undergoing somatic 
hypermutations in response to a foreign antigen (Figure 4, red 
line); in pathway two, they are derived from B cell progenitors 
expressing ANA-specific receptors that escape tolerance induc-
tion in the bone marrow, possibly by exposure to BCR crosslink-
ing by nuclear antigens (Figure 4, blue line). Indeed, we showed 
previously that anti-dsDNA reactive B  cells escaped tolerance 
FigUre 4 | Two distinct pathways generate ANA producing B cells. [(a) red background] B cells with a B-cell receptor (BCR) using a germline-encoded Vh1-26 in 
combination with a germline-encoded Vk4-74 gets stimulated by a non-self (NS) antigen/hapten. Due to somatic hypermutations in the Vk4-74 gene, ANA-reactive 
memory B cells are generated. In aging B6 mice, these memory cells are then activated by nuclear antigens and Th1 cells to produce ANA. In the GVHD mice, 
nuclear antigens and alloreactive T cells activate these memory cells, resulting in ANA formation. [(B) blue background] Immature B cells in the bone marrow with 
germline-encoded BCRs specific for nuclear antigens escape tolerance induction mechanisms through BCR cross-linking by a T cell independent type 2-antigen 
(TI-2) antigens or a signal from alloreactive T cells. In the periphery of aging B6 mice, these cells get stimulated by nuclear antigens and Th1 cells to produce ANAs. 
In the periphery of GVHD mice, nuclear antigens and alloreactive T cells activate these cells to ANA formation.
TaBle 3 | Vh-CDR2 regions of non-Vh1-26 ANA-reactive mAbs of graft-versus-host disease (GVHD) and aging B6 mice.a,b
Mouse number hybridoma number Vh-region Vh-cDr2 region Mouse number hybridoma number Vh-region Vh-cDr2 region
GVHD # 1 1.12.1A Vh8-8 I W W D D D Aging B6 # 1 7.F9.F1 Vh1-75 I L P G S G S S
1.308.1 Vh1-55 I Y P G S G S T
1.356.1 Vh1-55 I Y P G S G S T Aging B6 # 2 1.G5.B8 Vh1-39 V N P N Y G T I
1.741.1 Vh1-55 I Y P G S G S T
Aging B6 # 6 3.2.2A Vh1-74 I H P S D S D T
GVHD # 2 2.24.0 Vh1-52 I D P S D G e T Aging B6 # 6 6.15.1A Vh8-12 I Y W D D D K
2.53.8 Vh14-2 I D P e D G e T 7.7.3A Vh1-22 I N P N N G G T
2.58.2 Vh14-2 I D P e D G e S 20.15.1A Vh1-50 I D P S D T F T 
2.70.8 Vh14-4 I D P e N G D T 23.6.1A Vh1-22 I N P N N G D T
2.80.9 Vh14-4 I D P e N G D T 24.18.1A Vh1-22 I N P N N D D T
2.152.9 Vh1-52 I D P S D G e T 25.8.1A Vh3-6 I S C D G S S
2.300.2 Vh1-55 I Y P G S V S T
2.344.3 Vh1-52 I D P S D D e T Aging B6 # 7 3.25A Vh1-50 I D P S D T Y T 
2.382.2 Vh14-4 I D P e N G D T Aging B6 # 7 3.36A Vh1-80 I Y P G D G D T
2.388.2 Vh1-31 I F P Y N G V S
2.394.1 Vh14-4 I D P e N G D T
GVHD # 4 63.3.1 Vh1-55 I Y P G S G S T
165.2.1 Vh8-12 I Y W D D D K
GVHD # 5 14.11.A Vh1-50 I D P S D S Y I
381.11.A Vh1-54 I N P G S G G I
685.9.A Vh1-59 I D P S D S S S
762.5.A Vh5-17 I S r G S G I L
810.4.A Vh1-52 I D P S D S e T
865.12.A Vh1-72 I D P S S G G T
1011.39.A Vh1-53 I N P S N D G T
1011.39.A Vh1-53 I N P S N D G T
Bold font highlights negatively and positively charged amino acids.
aAll mAbs that were converted into germline sequences or in which the negatively charged amino acids in the CDR2 were converted into glycine are marked with orange boxes.
bAll the negatively charged amino acids in Vh-CDR2 region are marked in yellow and the positively charged amino acids in green.
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induction by the crosslinking of their BCRs by a T cell independ-
ent type 2-antigen (24).
restricted Diversity of ana specific  
B cells
Inspection of the V-region usage of ANA producing hybridomas 
shows that many ANAs derived from aging mice (21 of 36) 
(Table 1; Figure 4) and few from mice undergoing a cGVHD (6 of 
34) (Table 2; Figure 4) express Vh1-26 in combination with Vk4-
74. Interestingly this Vh/Vk combination is expressed in virtually 
all ANAs from aging mouse 1 (11 of 12), aging mouse 3 (6 of 6), 
and from the GVHD mouse 3 (5 of 5). Inspection of the V-regions 
strongly suggests that these ANAs are generated from single B cell 
clones with the exception of one clone of the GVHD mouse 3, 
which differs in the CDR3 compared to the other four. In other 
mice, ANAs are clearly generated from multiple B cell clones. In 
aging mouse 6, one ANA expresses the Vh1-26/Vk4-74 combina-
tion, one expresses the Vh1-26 with Vk4-61, two express the Vk4-
74 with Vh1-50 and Vh3-6, respectively, and five express different 
Vh/Vk combinations. In GVHD mice, all except one mouse (No. 
3) express ANAs derived from multiple B  cell clones. Thus, in 
aging B6 mice, the ANA repertoire tends to be restricted, while 
in GVHD mice, the ANA repertoire tends to be less restricted. 
The more important question to be answered is why ANAs are 
oligoclonal in some mice and polyclonal in others. One reason for 
this restricted repertoire might be that Vh1-26 and Vk4-74 genes 
are overrepresented in the B cell repertoire of B6 mice in general. 
RNA sequence analysis of Vh1 usage by B cells from young and 
aging B6 mice showed that around 10% of these used Vh1-26 
(our unpublished results). Since about 50% of all B  cells use a 
Vh1 family member, Vh1-26 is expressed by 5% of them. We did 
not attempt to verify this number in the hybrids generated, by, 
for example, cloning and sequencing the Vh regions of random 
IgM or IgG antibodies not reacting to nuclear antigens. With 
respect to Vk4-74 usage, Aoki-Ota et al. (31) analyzed the kappa 
light chain repertoire in B6 mice. This analysis revealed that B6 
B cells rarely use the Vk4-74 gene. We also have determined the 
Vk usage in developing B6 B  cells and found that Vk4-74 was 
used less than 1% in single Vk-rearrangements of preBII cells and 
immature B cells of the bone marrow [unpublished observation, 
(32)]. Thus, the restricted ANA-reactive B cell repertoire does not 
simply appear to reflect a selective usage of the Vh1-26 and the 
Vk4-74 genes by the B6 B cells. Instead, and more interestingly, 
this restricted ANA repertoire may occur through selection by 
and as yet to be defined T cell dependent antigen.
Many years ago, it was shown that haptens such as NP 
(4-hydoxy-3-nitrophenyl)acetyl (33, 34), oxazolone (2-phenyl-
5-oxazolone) (35, 36), and arsonate (p-azophenyl-arsonate) 
(37, 38) could elicit an oligoclonal humoral immune response, 
at least in certain inbred strains of mice. Based on this, one 
might envisage that a hapten-like structure is responsible for the 
restricted ANA-reactive B cell repertoire in aging B6 mice. Thus, 
one could imagine that the frequency of ANA-producing B cells 
that are derived from hapten-induced memory cells in aging mice 
(red pathway in Figure 4) is higher than the frequency of B cell 
progenitors with receptors for nuclear antigens that escape toler-
ance induction in the bone marrow (blue pathway in Figure 4).
activation of ana-Producing B cells
In ANA-producing mice, B  cells expressing nuclear antigen-
specific BCRs must be activated by nuclear antigens and helper 
T  cells. In GVHD mice, the alloreactive T  cells act as helper 
T cells. In their initial report on the “allogeneic effect,” Katz et al. 
reported a drastic enhancement of IgG responses as a result of 
a GVH reaction (39). Later, Osborne and Katz showed that a 
simple non-immunogenic hapten–polypeptide conjugate might 
elicit a vigorous primary IgG response as a consequence of the 
allogeneic effect (40). Likewise, Hamilton and Miller reported 
that otherwise tolerogenic hapten-conjugated syngeneic mouse 
erythrocytes would elicit a strong primary antibody response as 
a result of a GVH reaction (41). It is possible that this type of gen-
eral B cell help by alloreactive T cells contributes to the tendency 
of the ANA response in cGVHD mice to be more diverse.
In aging mice, the specificity and origin of the T helper cells 
that are required for ANA production is not known. Based on 
the IgG class of the ANAs produced in these mice, it is con-
ceivable that the helper cells involved in the ANA response are 
Th1 cells (30).
conclusions regarding the structure of 
anti-histone antibodies
Almost 30 years ago, Weigert and coworkers showed that arginine 
residues in CDR regions play a crucial role for the specificity of 
anti-dsDNA autoantibodies (10, 11). In the present study, we find 
an important role of arginine in the Vk-region of certain ANAs. 
Site-directed mutagenesis revealed that somatic mutations in 
the Vk4-74 light chains of the Vh1-26/Vk4-74 mAbs determine 
ANA reactivity, since conversion into their germline sequence 
completely abolished ANA reactivity. Interestingly, and highly 
significant, 20 of 23 Vh1-26/Vk4-74-expressing ANAs derived 
from aging B6 mice had a serine to arginine mutation at posi-
tion 30 in the CDR1 region of the Vk4-74 gene. In 1 of these 23 
mAbs, this change to arginine was the only mutation present in 
the entire Vk4-74 gene. The finding that one of these (17A9E6) 
mAb loses ANA-binding activity upon conversion of this arginine 
into serine strongly indicates the importance of this mutation for 
ANA reactivity. Furthermore, the introduction of single serine to 
arginine mutations in the germline configuration of three different 
mAbs conferred their antinuclear reactivity. This proves that this 
single mutation can convert an ANA-negative mAb into a positive 
one and clearly shows how easily Vh1-26/Vk4-74 using mAbs may 
become autoantibodies. The ANA-reactive B  cell repertoire has 
also been analyzed in B6 mice congenic for a SLE susceptibility 
locus. Also this analysis revealed a rather frequent usage of Vk4-74 
light chains. Thus, Liang et al. (12) found that 9 of 30 ANA pro-
ducing hybridomas used Vk4-74 light chain (herein called ai4). 
Moreover, it was shown that 3 of these 9 had a serine to arginine 
mutation at position 30 in the CDR1. In a report by Guo et al. (13), 
9 of 33 ANA-producing hybridomas used a Vk4-74 light chain 
(herein also called ai4). At least 5 of these 9 had a serine to arginine 
mutation at position 30 in the CDR1, like we report herein.
However, since 5 of 6 Vh1-26/Vk4-74 using mAbs derived 
from the GVHD mice did not have this serine to arginine muta-
tion, other mutations in the Vk4-74 gene can be involved in ANA 
reactivity.
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Yet, another interesting finding reported here is that a high 
percentage of ANA-reactive mAbs not using the Vh1-26 gene, 
especially in the repertoire derived from GVHD mice, possess 
a germline-encoded negatively charged Vh CDR2 region. Thus, 
14 of the total 34 monoclonal ANAs (41.2%) derived from the 
GVHD mice and 6 of 36 (16.7%) derived from the aging B6 mice 
have such a CDR2 region. Within the total Vh gene repertoire 
of B6 mice, 11.5% possess such a negatively charged CDR2 
(42). Thus, our findings suggest that B cells with such a charged 
CDR2 might be positively selected into the ANA-reactive B cell 
repertoire, especially in GVHD mice. The finding that mutations 
of these negatively charged amino acids into glycine can result 
in a complete loss of ANA binding supports this hypothesis 
and, moreover, indicates the potential importance of this region 
in ANA reactivity. However, additional structural effects of the 
amino acid change to glycine cannot be excluded, especially since 
glycine is known to be a helix breaker.
It is noteworthy that despite high ANA serum titers, aging 
B6 mice do not show the typical lesions that are observed in 
multiple organs of SLE patients, whereas the GVHD mice do 
show this. Therefore, one could envisage that the ANA reper-
toire difference between aging B6 and GVHD mice is playing 
a role in the pathogenesis of the SLE-like disease observed in 
GVHD mice.
Overall, the findings described in the present study highlight 
various new characteristics of ANA-reactive B cell repertoires and 
argue for similar mechanisms of ANA generation in SLE patients. 
This might improve our understanding of the pathogenesis of 
this disease, thereby opening new concepts and therapies for its 
control.
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